Optimization of ZD2 Peptide Targeted Gd(HP-DO3A) for Detection and Risk-Stratification of Prostate Cancer with MRI-Reference-Cited by-同舟云学术

Optimization of ZD2 Peptide Targeted Gd(HP-DO3A) for Detection and Risk-Stratification of Prostate Cancer with MRI

Published:2018-06-06 Issue:7 Volume:9 Page:730-735
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Ayat Nadia R.¹,Qin Jing-Can¹,Cheng Han¹,Roelle Sarah¹,Gao Songqi¹²,Li Yajuan²,Lu Zheng-Rong¹^ORCID

Affiliation:

1. Case Center for Biomolecular Engineering, Department of Biomedical Engineering, School of Engineering, Case Western Reserve University, Cleveland, Ohio 44106, United States

2. Molecular Theranostics, Cleveland, Ohio 44115, United States

Funder

National Cancer Institute

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.8b00172

Reference32 articles.

1. Screening: Diagnostic dilemma

2. Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer

3. Risk-Based Prostate Cancer Screening: Who and How?

4. Multi-parametric magnetic resonance imaging as a management decision tool

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MR Molecular Image Guided Treatment of Pancreatic Cancer with Targeted ECO/miR-200c Nanoparticles in Immunocompetent Mouse Tumor Models;Pharmaceutical Research;2024-08-28

2. MR Molecular Imaging of Extradomain-B Fibronectin for Assessing Progression and Therapy Resistance of Prostate Cancer;Chemical & Biomedical Imaging;2024-06-11

3. Assessment of the Efficacy of the Combination of RNAi of lncRNA DANCR with Chemotherapy to Treat Triple Negative Breast Cancer Using Magnetic Resonance Molecular Imaging;Bioconjugate Chemistry;2024-03-06

4. Pharmacokinetics and Tolerability of the Cancer-Targeting MRI Contrast Agent MT218 in Healthy Males;Investigative Radiology;2023-12-08

5. EDB-FN-Targeted Positron Emission Tomography Imaging of Breast Cancer in Mice;2023-10-30